The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer.
The role of positron emission tomography (PET) and PET/computed tomography (CT) in the management of pancreatic cancer patients has not been clearly established. Although value of PET/CT in the staging of pancreatic cancer is still being debated, several studies pointed to its superior role in determining therapy response, recurrence detection, and survival prediction in comparison to conventional imaging including contrast-enhanced CT. This article reviews the current literature on usefulness of PET/CT in the management of pancreatic cancer patients.
From the *Russell H Morgan Department of Radiology and Radiological Sciences, †Department of Oncology, Johns Hopkins School of Medicine, and ‡Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Pratyusha
P
Nunna
Sara
S
Sheikhbahaei
Sejin
S
Ahn
Brenda
B
Young
Rathan M
RM
Subramaniam
D003287:Contrast Media; D003937:Diagnosis, Differential; D006801:Humans; D064847:Multimodal Imaging; D010179:Pancreas / Q000000981:diagnostic imaging; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D011856:Radiographic Image Enhancement; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed
D003287:Contrast Media